The Clorox Company (BVMF:CLXC34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 58.79B -33.1% |
| Revenue (ttm) | 35.27B -3.7% |
| Net Income | 3.94B +8.9% |
| EPS | 32.19 +10.8% |
| Shares Out | n/a |
| PE Ratio | 14.91 |
| Forward PE | 16.32 |
| Dividend | 4.45 (3.58%) |
| Ex-Dividend Date | Apr 20, 2026 |
| Volume | 2 |
| Open | 124.15 |
| Previous Close | 124.45 |
| Day's Range | 124.07 - 124.15 |
| 52-Week Range | 101.00 - 183.06 |
| Beta | 0.53 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 3, 2026 |
About The Clorox Company
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service p... [Read more]
Financial Performance
In fiscal year 2025, The Clorox Company's revenue was $7.10 billion, an increase of 0.16% compared to the previous year's $7.09 billion. Earnings were $810.00 million, an increase of 189.29%.
Financial numbers in USD Financial StatementsNews
Clorox price target raised to $86 from $85 at Barclays
Barclays raised the firm’s price target on Clorox (CLX) to $86 from $85 and keeps an Underweight rating on the shares. The firm adjusted targets in the consumer staples group…
Top 10 Dividend Stocks to Buy in 2026
In this bonus episode of The Morning Filter podcast, co-hosts Dave Sekera and Susan Dziubinski talk dividend stock investing. They unpack the performance of dividend stocks during the first half of 20...
Clorox price target raised to $100 from $96 at UBS
UBS raised the firm’s price target on Clorox (CLX) to $100 from $96 and keeps a Neutral rating on the shares.
Clorox price target lowered to $92 from $95 at JPMorgan
JPMorgan lowered the firm’s price target on Clorox (CLX) to $92 from $95 and keeps an Underweight rating on the shares. The firm adjusted targets in the beverage, household and…
Clorox Announces August 3 Webcast of Fourth-Quarter and Fiscal Year 2026 Results
OAKLAND, Calif., July 13, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its fourth-quarter and fiscal year 2026 results on August 3, 2026.
Why Verizon, Clorox and More Dividend Stocks Are Flashing a Buy Signal
It's the right time to jump in on dividend stocks. Clorox, Pfizer, Verizon and Comcast are some of the names to consider.
Clorox implements reorganization of operating structure
Clorox (CLX) announced a simplified operating structure designed to streamline leadership oversight, align resources to drive the company’s growth opportunities, advance portfolio optimization efforts...
Clorox Announces Simplified Operating Structure to Improve Execution and Accelerate Growth
OAKLAND, Calif., June 17, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced a simplified operating structure designed to streamline leadership oversight, align resources to drive the...
3 Stocks to Invest In to Rebalance Your Portfolio
#TheMorningFilter #PortfolioRebalance #StockInvesting These value stocks can balance portfolios heavy in growth stocks—and they're undervalued, too. Watch The Morning Filter: https://www.youtube.com/l...
The Clorox Company Transcript: 23rd annual dbAccess Global Consumer Conference
Leadership transition is underway with no immediate operational changes. The business is stabilizing after a major ERP upgrade, focusing on innovation and market share gains amid a volatile consumer environment. GOJO integration is progressing well, with financial discipline and digital transformation supporting future growth.
Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges
Clorox Healthcare launches two new innovative products designed to help close a critical compliance gap in daily disinfection: Clorox Healthcare Quat Alcohol Disinfecting Wipes, featuring a 1-minute c...
Clorox CEO stepping down for health reasons, company to begin CEO search
Clorox (CLX) CEO Linda Rendle has asked the Board of Directors to initiate a CEO search process, as she has made the decision to step down for health reasons. Rendle…
Clorox CEO to Step Down for Health Reasons
Clorox Chief Executive Officer Linda Rendle is stepping down for health reasons after more than 20 years at the company.
Clorox Board of Directors to Initiate Comprehensive CEO Search Process
Chair and CEO Linda Rendle to Step Down Following Appointment of New CEO OAKLAND, Calif., May 28, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Of...
Glad® Features Sesame Street's Oscar the Grouch in new Limited-Edition Packaging
New collaboration brings a playful twist to everyday trash routines, turning a household chore into a moment of humor and personality. OAKLAND, Calif.
Clorox to Present at dbAccess Global Consumer Conference
OAKLAND, Calif., May 13, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle and Chief Financial Officer Luc Bellet will participate...
Hidden Valley™ Ranch Expands into Protein-Forward Snacking with New Line of Seasoned Chicken Dippers
Iconic Ranch Flavor Meets Ready ‑ to ‑ Eat Chicken in a New Product that Answers Consumers' Growing Need for Protein and Convenience LAS VEGAS, May 11, 2026 /PRNewswire/ -- Hidden Valley Ranch, the br...
The Clorox Company Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of The Clorox Company (NYSE: CLX). The investigation focuses on Clorox's execu...
Clorox price target lowered to $83 from $94 at Goldman Sachs
Goldman Sachs analyst Bonnie Herzog lowered the firm’s price target on Clorox (CLX) to $83 from $94 and keeps a Sell rating on the shares. Clorox reported a slight EPS…
Clorox price target lowered to $97 from $110 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Clorox (CLX) to $97 from $110 and keeps an Equal Weight rating on the shares. Sales struggles are persisting, particularly in litter…
Clorox price target lowered to $95 from $99 at JPMorgan
JPMorgan lowered the firm’s price target on Clorox (CLX) to $95 from $99 and keeps an Underweight rating on the shares.
Clorox price target lowered to $110 from $115 at Evercore ISI
Evercore ISI analyst Javier Escalante lowered the firm’s price target on Clorox (CLX) to $110 from $115 and keeps an Underperform rating on the shares.
Clorox price target lowered to $91 from $100 at Deutsche Bank
Deutsche Bank analyst Steve Powers lowered the firm’s price target on Clorox (CLX) to $91 from $100 and keeps a Hold rating on the shares.
Clorox price target lowered to $97 from $110 at Citi
Citi lowered the firm’s price target on Clorox (CLX) to $97 from $110 and keeps a Neutral rating on the shares. The firm updated the company’s model post the earnings…
Clorox price target lowered to $96 from $110 at UBS
UBS lowered the firm’s price target on Clorox (CLX) to $96 from $110 and keeps a Neutral rating on the shares. Clorox beat Q3 EPS expectations on lower SG&A but…